CHICAGO, May 30, 2022 /PRNewswire/ -- According to the new market research report "Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) - Global Forecast to 2027", published by MarketsandMarkets, the global market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027.
Browse in-depth TOC on "Particle Therapy Market"
168 - Tables
46 - Figures
209 - Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12809137 https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209565994&utm_source=prnewswire&utm_medium=referral&utm_campaign=paidpr
In this report, the market is segmented on the basis of type, products and services, cancer type, systems, and region.
"Pediatric cancer defined for the largest share in the particle therapy market by cancer type"
Based on cancer type, the market is segmented into prostate cancer. pediatric cancer, lung cancer, breast cancer, head & neck cancer, and other cancers. The pediatric cancer segment holds the largest share of 24.8% of the market in 2021 with CAGR of 10.4% during the forecast period. The growing incidence of pediatric cancer alongside the high success rates is the major factors driving the growth of this market segment.
"Products such as cyclotron accounted for the largest share in the particle therapy market by product type"
Based on products & services, the market is segmented into products and services. In 2021, products are estimated to account for the largest share of 78.6% of the particle therapy market. The increasing incidence of cancer cases is the major factor responsible for the growth of this segment.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=12809137
"Based on system, multi-room systems holds the largest share in the particle therapy"
Based on the system, the particle therapy market is segmented into single-room and multi-room particle therapy systems. The multi-room systems segment is expected to account for the largest share (67.8%) of the market. The large share of this segment can be attributed to the growing availability of these systems and their lower shielding requirements as compared to single-room systems.
Key Market Players:
Prominent players in the particle therapy market include IBA Worldwide (EU), Mevion Medical Systems (US), Varian Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Hitachi, Ltd. (Japan), Toshiba Medical Systems Corporation (Japan), and Provision Healthcare, LLC (US). These players have implemented various development strategies such as product launches, acquisition, and expansion to other geography.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=12809137
Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting
Browse Related Reports:
Radiotherapy Market by Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Procedure (External (IMRT, IGRT, 3D-CRT) Internal (LDR, HDR)), Application (Prostate, Breast, Lung), End User (Hospitals) - Global Forecasts to 2026
https://www.marketsandmarkets.com/Market-Reports/radiotherapy-monitoring-devices-market-567.html
Interventional Oncology Market by Product (Radiofrequency, microwave, embolization, guidewires), Procedure (Thermal, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung, Kidney, Bone Metastasis), Enduser (Hospital, ASC) - Global Forecast to 2026
https://www.marketsandmarkets.com/Market-Reports/interventional-oncology-market-203687164.html
About MarketsandMarkets
MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/particle-therapy-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/particle-therapy.asp
Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
